Aphios
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3-e Boston Park, Woburn, Massachusetts, ...Phone Number
(781) 932-6933Website
www.aphios.comRevenue
$5.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Aphios
Aphios (www.aphios.com) is an emerging growth, green biotechnology company developing enabling technology platforms to improve drug discovery and manufacturing, nanotechnology drug delivery and pathogenic safety. Based on these platforms, Aphios is developing enhanced therapeutics to improve quality-of-life and treat chronic diseases including cancers, infectious diseases such as HIV/AIDS, and central nervous system disorders in an environmentally sustainable manner.Explore more
Aphios Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aphios your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Aphios has new funding data
Check if Aphios has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Aphios launches new products
Click to see if Aphios had a recent Job posting/layoffs
Earning: See what the market has to say on Aphios recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Aphios
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Aphios is spiking on competitors!
Aphios, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Aphios
Compare insights from companies similar to Aphios, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Aphios is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Aphios is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Aphios.
Aphios financials insights
Gather financial insights about Aphios, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
2022
Other Financing Round
$93K
Aphios Tech Stack
A closer look at the technologies used by Aphios
Most Recent Scoops
Open Position
Open Position
Open Position
Funding
Project
Spending/Investment, Funding
Funding
Project
Award, Spending/Investment, Product Development, Safety, Health & Safety
Aphios News & Media
Aphios Granted US Patent for Thermal Conversion of CBDA and Other Carboxylic Acid Cannabinoids
NORTH READING, Mass.--(BUSINESS WIRE)-- #Acid--Aphios announced today that it was granted US Patent No. 11,981,174 for the thermal conversion of CBDA to CBD and other carboxylic acid cannabinoids to cannabinoids. The patent was granted for a process to improve the manufacturing of pharmaceutical grade CBD and other cannabinoids following current Good Manufacturing Practices (cGMP) of the US FDA. The major cannabinoids in marijuana (Cannabis) originate from cannabigerolic acid (CBGA) and are convAphios Awarded NIH SBIR Grant For Development of Anti-CCR5 Nanoparticles to Treat Alzheimer’s Disease
NORTH READING, Mass.--(BUSINESS WIRE)-- #Alzheimersdisease--Aphios announced today that it was awarded an NIH SBIR grant from the National Institute on Aging (NIA) to develop anti-CCR5 nanoparticles to treat Alzheimer’s disease. Alzheimer's disease and dementia are debilitating diseases affecting over 6.7 million people in the United States and over 55 million people worldwide. Alzheimer's disease has been characterized by multiple factors, including but not limited to amyloid plaque formation,Aphios Corporation Granted Japanese Patent for Novel Compositions to Treat Folic Acid Deficiency and Morning Sickness
NORTH READING, Mass.--(BUSINESS WIRE)-- #Biodegradable--Aphios Corporation announced today that it has been granted Japanese Patent No. 7,520,838 for novel compositions to treat folic acid deficiency and morning sickness. The dosage forms have an effective amount of a folic acid, gingerols and shogaols to suppress nausea, relieve gastric distress and promote hematopoiesis. Pregnancy related nausea and vomiting (PRNV) is the most common medical condition during pregnancy. PRNV affects up to 70% oAphios Granted US Patent For siRNA Targeted Therapeutics for Treatment of HIV-1 and Other Diseases
WOBURN, Mass.--(BUSINESS WIRE)-- #AIDS--Aphios Corporation announced today that it has been granted US Patent No. 11,981,174 for CCR5 and CD4 siRNA-targeted therapeutics for treatment of HIV-1 and other diseases. More than 35 million people have died from AIDS, and 37 million people are living with HIV worldwide. In the United States, an estimated 1.2 million people are currently living with HIV and approximately 40,000 infections occur each year. There is no vaccine against HIV, and
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Aphios
Sign Up For FreeTo access detailed company insights
Aphios (www.aphios.com) is an emerging growth, green biotechnology company developing enabling technology platforms to improve drug discovery and manufacturing, nanotechnology drug delivery and pathogenic safety. Based on these platforms, Aphios is developing enhanced therapeutics to improve quality-of-life and treat chronic diseases including canc... Read More
